Pain, postoperative, Obesity
Conditions
Brief summary
No difference in patient-reported pain score according to NRS (Numeric Rating Scale, 0-10), calculated as a deviation of one scale step within the NRS scale, between the intervention group patients compared to conventional treatment (control group) postoperatively. NRS (numeric rating scale for pain) during the last 24 hours (scale 0-10, 'no pain' vs. 'worst imaginable pain').
Detailed description
An opioid-sparing treatment provides improved combined outcomes (composite score) consisting of 1) Self-Efficacy, 2) Postoperative Quality of Recovery Scale (PQRS), hospital readmission, or death at 3 months compared to conventional treatment., An opioid-sparing treatment results in reduced opioid consumption during the peri- and postoperative period until discharge to the ward compared to conventional treatment., An opioid-sparing treatment results in reduced opioid consumption throughout the hospital stay compared to conventional treatment., An opioid-sparing treatment results in decreased pain experience according to the Numeric Rating Scale (NRS) at 3 months and 6 months compared to conventional treatment., An opioid-sparing treatment leads to earlier recovery after surgery measured with PQRS compared to conventional treatment postoperatively (20 minutes, 40 minutes), during hospitalization (24-72 hours), and thereafter (14 days, 30 days, 3 months, 6 months, 12 months, and 24 months)., An opioid-sparing treatment increases confidence in coping with unexpected events measured with the General Self-Efficacy Scale compared to conventional treatment after the in-hospital period (3 months, 6 months, 12 months, 24 months)., An opioid-sparing treatment improves quality of life measured with RAND-36 and EQ5D compared to conventional treatment after the in-hospital period (3 months, 6 months, 12 months, 24 months)., An opioid-sparing treatment results in equivalent length of hospital stay compared to conventional treatment during the in-hospital period., Mapping of long-term prescription of analgesic drugs. Does an opioid-sparing treatment impact the long-term use of analgesic medications.
Interventions
Sponsors
Eligibility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| No difference in patient-reported pain score according to NRS (Numeric Rating Scale, 0-10), calculated as a deviation of one scale step within the NRS scale, between the intervention group patients compared to conventional treatment (control group) postoperatively. NRS (numeric rating scale for pain) during the last 24 hours (scale 0-10, 'no pain' vs. 'worst imaginable pain'). | — |
Secondary
| Measure | Time frame |
|---|---|
| An opioid-sparing treatment provides improved combined outcomes (composite score) consisting of 1) Self-Efficacy, 2) Postoperative Quality of Recovery Scale (PQRS), hospital readmission, or death at 3 months compared to conventional treatment., An opioid-sparing treatment results in reduced opioid consumption during the peri- and postoperative period until discharge to the ward compared to conventional treatment., An opioid-sparing treatment results in reduced opioid consumption throughout the hospital stay compared to conventional treatment., An opioid-sparing treatment results in decreased pain experience according to the Numeric Rating Scale (NRS) at 3 months and 6 months compared to conventional treatment., An opioid-sparing treatment leads to earlier recovery after surgery measured with PQRS compared to conventional treatment postoperatively (20 minutes, 40 minutes), during hospitalization (24-72 hours), and thereafter (14 days, 30 days, 3 months, 6 months, 12 months, and 24 month | — |
Countries
Sweden